High early mortality following percutaneous nephrostomy in metastatic cancer: a national analysis of outcomes.
Amandeep DosanjhBenjamin CouplandJemma MyttonDominic Stephen KingHarriet MintzAnna LockVeronica NantonParam MariappanNigel TrudgillPrashant PatelPublished in: BMJ supportive & palliative care (2024)
The decision to undertake nephrostomy in patients with poor prognosis cancer is complex and should be undertaken in a multidisciplinary team setting. Complication rates are high and minimal survival benefit is derived in many patients, especially in the context of emergency inpatient care.
Keyphrases
- poor prognosis
- papillary thyroid
- quality improvement
- palliative care
- end stage renal disease
- long non coding rna
- healthcare
- squamous cell
- newly diagnosed
- chronic kidney disease
- ejection fraction
- squamous cell carcinoma
- small cell lung cancer
- emergency department
- public health
- peritoneal dialysis
- prognostic factors
- lymph node metastasis
- type diabetes
- minimally invasive
- risk factors
- childhood cancer
- pain management
- patient reported outcomes
- adipose tissue
- weight loss
- glycemic control